Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRP vs Corticosteroid in Pes Anserinus Pain Syndrome
NCT06453603Not yet recruiting
- Sponsor
- Ramathibodi Hospital
- Start
- Jul 2024
- Primary completion
- Dec 2026
- Modality
- Adipose-derived MSCs, Bone Marrow MSCs
01
Overview
Randomised, single-blind trial of platelet-rich plasma in Pes anserine bursitis (PAB) (2 arms), sponsored by Ramathibodi Hospital. Primary endpoint: Visual Analogue Scale at 6 months. Planned start Jul 2024; status: not yet recruiting.
02
Drugs
platelet-rich plasma
03
Conditions
Pes anserine bursitis (PAB)
Beyond the preview
Go deeper on NCT06453603.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06453603.